Scholarlink

<p>Pelvic floor disorders (PFDs) — which include pelvic organ prolapse, urinary incontinence, perineal trauma, fecal incontinence, and sexual dysfunction <b>—</b> affect one in four women globally. There is compelling epidemiological and pathophysiological evidence that these conditions result from childbirth trauma. Yet chronic maternal pelvic morbidity remains a neglected issue within the maternal health agenda worldwide. Current health systems limit public health approaches to maternal health to just 6 weeks after birth, overlooking the long-term pelvic floor consequences of childbirth trauma. In many countries, women suffering from PFDs often face stigma, cultural isolation, and economic hardship yet have little access to care owing to cultural taboos, policy-based neglect, systemic under-reporting and underinvestment, and limited preventive and cost-effective care frameworks within the public health system. This white paper advocates for the extension of the paradigm of maternal health beyond 6 weeks postpartum to encompass all the repercussions of childbirth pelvic floor trauma, irrespective of the timeframe of their development. It concludes with a call to action urging multilateral agencies, national health ministries, policymakers, urogynecologists, public health professionals, and the social sector to join forces in a coordinated multisectoral response. Addressing chronic maternal pelvic morbidity requires the inclusion of pelvic health services within existing maternal and reproductive health programs, the development of global public health guidelines that prioritize prevention&#xa0;and timely management, and the&#xa0;training of health care providers at all levels of the health system. This white paper asks for sustained policy support, greater investment in research and the development of cost-effective therapies, stronger advocacy, and integration with existing programs such as fistula care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Chronic Maternal Pelvic Morbidity: A Neglected Tragedy: Where is Pelvic Maternal Morbidity in Maternal and Child Health? 

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月9日

查看全文
  • Aparna Hegde,
  • Judith Goh,
  • Rohna Kearney,
  • Yu Hwee Tan,
  • Cristiane Carboni,
  • Karishma Thariani,
  • Zelalem Mengistu,
  • Maria Giroux

摘要

Pelvic floor disorders (PFDs) — which include pelvic organ prolapse, urinary incontinence, perineal trauma, fecal incontinence, and sexual dysfunction — affect one in four women globally. There is compelling epidemiological and pathophysiological evidence that these conditions result from childbirth trauma. Yet chronic maternal pelvic morbidity remains a neglected issue within the maternal health agenda worldwide. Current health systems limit public health approaches to maternal health to just 6 weeks after birth, overlooking the long-term pelvic floor consequences of childbirth trauma. In many countries, women suffering from PFDs often face stigma, cultural isolation, and economic hardship yet have little access to care owing to cultural taboos, policy-based neglect, systemic under-reporting and underinvestment, and limited preventive and cost-effective care frameworks within the public health system. This white paper advocates for the extension of the paradigm of maternal health beyond 6 weeks postpartum to encompass all the repercussions of childbirth pelvic floor trauma, irrespective of the timeframe of their development. It concludes with a call to action urging multilateral agencies, national health ministries, policymakers, urogynecologists, public health professionals, and the social sector to join forces in a coordinated multisectoral response. Addressing chronic maternal pelvic morbidity requires the inclusion of pelvic health services within existing maternal and reproductive health programs, the development of global public health guidelines that prioritize prevention and timely management, and the training of health care providers at all levels of the health system. This white paper asks for sustained policy support, greater investment in research and the development of cost-effective therapies, stronger advocacy, and integration with existing programs such as fistula care.